SNCA and Parkinson disease: (Tysnes and Storstein, 2017) Pathological changes in PD primarily involve abnormal aggregation of α-synuclein in dopaminergic neurons in the substantia nigra pars compacta (SNpc) and progressive loss of dopaminergic neurons.